Fife, United Kingdom

John Derek Woollins

This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: Eastman Chemical Company. Active years: 2018-2021.

USPTO Granted Patents = 3 

% Patents Active = 33.3


Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Derek Woollins: Innovator in Sulfur Allotropes

Introduction

John Derek Woollins is a notable inventor based in Fife, GB. He has made significant contributions to the field of chemistry, particularly in the area of sulfur allotropes. With a total of 3 patents to his name, Woollins has established himself as a key figure in his domain.

Latest Patents

Woollins' latest patents include a method for the manufacture of cyclododecasulfur. This invention relates to a cyclic sulfur allotrope where the number of sulfur (S) atoms in the homocyclic ring is 12. The method involves reacting a metallasulfur derivative with an oxidizing agent in a reaction zone to create a cyclododecasulfur-containing reaction mixture. This innovative approach has the potential to advance the production of sulfur allotropes significantly.

Career Highlights

Woollins is currently associated with Eastman Chemical Company, where he continues to explore and develop new chemical processes. His work has garnered attention for its practical applications in various industries.

Collaborations

Throughout his career, Woollins has collaborated with esteemed colleagues such as Scott Donald Barnicki and Robert Thomas Hembre. These partnerships have contributed to the advancement of his research and innovations.

Conclusion

John Derek Woollins is a distinguished inventor whose work in the field of sulfur allotropes has made a lasting impact. His innovative methods and collaborations highlight his commitment to advancing chemical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…